What is CVE-2020-27262?

CVE-2020-27262 is a medium-severity vulnerability in Innokasmedical Vital Signs Monitor Vc150, classified under Cross-site Scripting. CVSS score: 5.4/10. Published 2021-01-08.

How severe is CVE-2020-27262?

Medium severity. CVSS v3 base score is 5.4 out of 10.

XSS in Innokasmedical Vital Signs Monitor Vc150

CVE-2020-27262

Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 A stored cross-site scripting (XSS) vulnerability exists in the affected products that allow an attacker to inject arbitrary web script or HTML via the filename parameter to multiple update endpoints of the administrative web interface.

Vulnerability class: XSS (Cross-Site Scripting)

EPSS: 0.007 (48.5th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 5.4 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N.

Affected products

Innokasmedical Vital_signs_monitor_vc150
Innokasmedical Vital_signs_monitor_vc150_firmware
N/a Innokas Yhtymä Oy Vital Signs Monitor Vc150 — versions VC150 prior to Version 1.7.15

Weakness classification (CWE)

CWE-79 — Cross-site Scripting

References

ics-cert@hq.dhs.gov (US Government Resource, Third Party Advisory, x_refsource_MISC)

Frequently asked questions

What is CVE-2020-27262?: CVE-2020-27262 is a medium-severity vulnerability in Innokasmedical Vital Signs Monitor Vc150, classified under Cross-site Scripting. CVSS score: 5.4/10. Published 2021-01-08.
How severe is CVE-2020-27262?: Medium severity. CVSS v3 base score is 5.4 out of 10.